Apoptosis inducers in chronic lymphocytic leukemia
Apoptosis inducers in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.1480
Christian Billard
|
| 309-325 |
Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer |
|
https://doi.org/10.18632/oncotarget.1545
Ho Kyung Seo,
Kyung-Ohk Ahn,
Nae-Rae Jung,
Ji-Sun Shin,
Weon Seo Park,
Kang-Hyun Lee,
Sang-Jin Lee,
and Kyung-Chae Jeong
|
| 326-337 |
Pharmacokinetic modeling optimizes inhibition of the ‘undruggable’ EWS-FLI1 transcription factor in Ewing Sarcoma
Pharmacokinetic modeling optimizes inhibition of the ‘undruggable’ EWS-FLI1 transcription factor in Ewing Sarcoma |
|
https://doi.org/10.18632/oncotarget.1495
Sung-Hyeok Hong,
Sarah E. Youbi,
S. Peter Hong,
Bhaskar Kallakury,
Phillip Monroe,
Hayriye V. Erkizan,
Julie S. Barber-Rotenberg,
Peter Houghton,
Aykut Üren,
and Jeffrey A. Toretsky
|
| 338-350 |
ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells
ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells |
|
https://doi.org/10.18632/oncotarget.1449
Liliana H. Mochmann,
Martin Neumann,
Eva K. von Der Heide,
Verena Nowak,
Anja A. Kühl,
Jutta Ortiz-Tanchez,
Juliane Bock,
Wolf K Hofmann,
and Claudia D Baldus
|
| 351-362 |
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma |
|
https://doi.org/10.18632/oncotarget.1620
Lotte Hiddingh,
Bakhos A. Tannous,
Jian Teng,
Bas Tops,
Judith Jeuken,
Esther Hulleman,
Sandra H. Boots-Sprenger,
W. Peter Vandertop,
David P. Noske,
Gertjan J.L. Kaspers,
Pieter Wesseling,
and Thomas Wurdinger
|
| 363-374 |
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine |
|
https://doi.org/10.18632/oncotarget.1568
Elisabeth Walsby,
Guy Pratt,
Hao Shao,
Abdullah Y. Abbas,
Peter M. Fischer,
Tracey D. Bradshaw,
Paul Brennan,
Chris Fegan,
Shudong Wang,
and Chris Pepper
|
| 375-385 |
CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus
CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus |
|
https://doi.org/10.18632/oncotarget.1566
Andrew J. Murphy,
Janene Pierce,
Christian de Caestecker,
Gregory D. Ayers,
Alex Zhao,
Jonathan R. Krebs,
Vincente Kenyi Saito-Diaz,
Ethan Lee,
Alan O. Perantoni,
Mark P. de Caestecker,
and Harold N. Lovvorn, III
|
| 386-402 |
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing |
|
https://doi.org/10.18632/oncotarget.1719
Sofia R. Gameiro,
Momodou L. Jammeh,
Max M. Wattenberg,
Kwong Y. Tsang,
Soldano Ferrone,
and James W. Hodge
|
| 403-416 |
Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites
Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites |
|
https://doi.org/10.18632/oncotarget.1708
Catherine A. Vaughan,
Swati P. Deb,
Sumitra Deb,
and Brad Windle
|
| 417-427 |
Minor grove binding ligands disrupt PARP-1 activation pathways
Minor grove binding ligands disrupt PARP-1 activation pathways |
|
https://doi.org/10.18632/oncotarget.1742
Kirill Kirsanov,
Elena Kotova,
Petr Makhov,
Konstantin Golovine,
Ekaterina A. Lesovaya,
Vladimir M. Kolenko,
Marianna G. Yakubovskaya,
and Alexei V. Tulin
|
| 428-437 |
RB1 gene inactivation by chromothripsis in human retinoblastoma
RB1 gene inactivation by chromothripsis in human retinoblastoma |
|
https://doi.org/10.18632/oncotarget.1686
Justina McEvoy,
Panduka Nagahawatte,
David Finkelstein,
Jennifer Richards-Yutz,
Marcus Valentine,
Jing Ma,
Charles Mullighan,
Guangchun Song,
Xiang Chen,
Matthew Wilson,
Rachel Brennan,
Stanely Pounds,
Jared Becksfort,
Robert Huether,
Charles Lu,
Robert S. Fulton,
Lucinda L. Fulton,
Xin Hong,
David J. Dooling,
Kerri Ochoa,
Elaine R. Mardis,
Richard K. Wilson,
John Easton,
Jinghui Zhang,
James R. Downing,
Arupa Ganguly,
and Michael A. Dyer
|
| 438-450 |
GATA2 as a potential metastasis-driving gene in prostate cancer
GATA2 as a potential metastasis-driving gene in prostate cancer |
|
https://doi.org/10.18632/oncotarget.1296
Yan Ting Chiang,
Kendric Wang,
Ladan Fazli,
Robert Z. Qi,
Martin E. Gleave,
Colin C. Collins,
Peter W. Gout,
and Yuzhuo Wang
|
| 451-461 |
Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma
Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma |
|
https://doi.org/10.18632/oncotarget.1552
Uwe Schirmer,
Kai Doberstein,
Anne-Kathleen Rupp,
Niko P. Bretz,
Daniela Wuttig,
Helena Kiefel,
Christian Breunig,
Heidi Fiegl,
Elisabeth Müller-Holzner,
Robert Zeillinger,
Eva Schuster,
Alain G. Zeimet,
Holger Sültmann,
and Peter Altevogt
|
| 462-472 |
Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers
Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers |
|
https://doi.org/10.18632/oncotarget.1631
Ai-Sheng Ho,
Chien-Hsin Chen,
Chun-Chia Cheng,
Chia-Chi Wang,
Hua-Ching Lin,
Tsai-Yueh Luo,
Gi-Shih Lien,
and Jungshan Chang
|
| 473-480 |
Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function |
|
https://doi.org/10.18632/oncotarget.1664
Bongkun Choi,
Eun-Jin Lee,
Da-Hyun Song,
Sung-Chul Yoon,
Yeon-Ho Chung,
Yongsaeng Jang,
Sang-Min Kim,
Youngsup Song,
Sang-Wook Kang,
Seung-Yong Yoon,
and Eun-Ju Chang
|
| 481-492 |
NF-κB1 inhibits c-Myc protein degradation through suppression of FBW7 expression
NF-κB1 inhibits c-Myc protein degradation through suppression of FBW7 expression |
|
https://doi.org/10.18632/oncotarget.1643
Haishan Huang,
Li Ma,
Jingxia Li,
Yonghui Yu,
Dongyun Zhang,
Jinlong Wei,
Honglei Jin,
Derek Xu,
Jinmin Gao,
and Chuanshu Huang
|
| 493-505 |
Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma
Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.1529
Nicole M.A. White,
Olena Masui,
Leroi V. DeSouza,
Olga Krakovska,
Shereen Metias,
Alexander D. Romaschin,
R.John Honey,
Robert Stewart,
Kenneth Pace,
Jason Lee,
Michael AS. Jewett,
Georg A. Bjarnason,
K.W.Michael Siu,
and George M. Yousef
|
| 506-518 |
Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells
Collagen triple helix repeat containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells |
|
https://doi.org/10.18632/oncotarget.1714
Hee Cheol Kim,
Yong Sung Kim,
Hyun-Woo Oh,
Kwoneel Kim,
Sang-Seok Oh,
Jong-Tae Kim,
Bo Yeon Kim,
Seon-Jin Lee,
Yong-Kyung Choe,
Dong Hyeok Kim,
Seok-Hyung Kim,
Seoung Wan Chae,
Kwang Dong Kim,
and Hee Gu Lee
|
| 519-529 |
First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines
First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines |
|
https://doi.org/10.18632/oncotarget.1528
Senthilmurugan Ramalingam,
Lalji Gediya,
Andrew K. Kwegyir-Afful,
Vidya P. Ramamurthy,
Puranik Purushottamachar,
Hannah Mbatia,
and Vincent C.O. Njar
|
| 530-543 |
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation |
|
https://doi.org/10.18632/oncotarget.1652
Zhi-Qiang Wang,
Magdalena Bachvarova,
Chantale Morin,
Marie Plante,
Jean Gregoire,
Marie-Claude Renaud,
Alexandra Sebastianelli,
and Dimcho Bachvarov
|
| 544-560 |
HIF-1α downregulation and apoptosis in hypoxic prostate tumor cells infected with oncolytic Mammalian Orthoreovirus
HIF-1α downregulation and apoptosis in hypoxic prostate tumor cells infected with oncolytic Mammalian Orthoreovirus |
|
https://doi.org/10.18632/oncotarget.1767
Pooja Gupta-Saraf,
and Cathy L. Miller
|
| 561-574 |
